Bora Pharmaceuticals is leaning harder into contract drug manufacturing and rare‑disease medicines, aiming to move away from lower‑profit generic drugs and build a steadier, higher‑quality business. The big question is whether new capacity, recent deal-making, and a growing project pipeline can turn into dependable sales—before pricing pressure and U.S. policy uncertainty slow things down.Read more
Bora Pharmaceuticals is riding a push to make more medicines closer to home, but it’s also building new capacity that could take time to fill. The big question is whether its move toward higher-value neurology and complex medicines can lift profits fast enough before competition, execution hiccups, or shifting policy winds get in the way.Read more
Bora Pharmaceuticals is bouncing back from recent production setbacks and is leaning hard into making higher-value medicines, with a big push to expand its contract manufacturing footprint in the US. The upside comes from winning more large pharma clients and building longer-term, repeat business, but the story depends on executing major facility expansions and keeping a few key customers.Read more
No trending discussion available.
Bora Pharmaceuticals Co., Ltd. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibiotics, and gastrointestinal medications; and nutritional and vitamin supplements, physical recovery, and health care products. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., Ltd. was incorporated in 2007 and is based in Taipei City, Taiwan.
